{
 "cells": [
  {
   "cell_type": "markdown",
   "id": "77dfe896",
   "metadata": {},
   "source": [
    "# Memory Management - Part 1 - Agent Sessions\n",
    "\n",
    "**Day 3A â€” Google ADK | Local VS Code**\n",
    "\n",
    "Youâ€™ll build:\n",
    "- Stateful agents\n",
    "- Sessions & events\n",
    "- Persistent storage\n",
    "- Context compaction\n",
    "\n",
    "---\n",
    "**No Kaggle. Just code.**"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "207dc896",
   "metadata": {},
   "source": [
    "### Load API Key"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 1,
   "id": "c067ab63",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Gemini API key loaded!\n"
     ]
    }
   ],
   "source": [
    "import os\n",
    "from dotenv import load_dotenv\n",
    "\n",
    "load_dotenv()\n",
    "\n",
    "GOOGLE_API_KEY = os.getenv(\"GOOGLE_API_KEY\")\n",
    "if not GOOGLE_API_KEY:\n",
    "    raise ValueError(\"Add GOOGLE_API_KEY to .env in project root!\")\n",
    "\n",
    "os.environ[\"GOOGLE_API_KEY\"] = GOOGLE_API_KEY\n",
    "os.environ[\"GOOGLE_GENAI_USE_VERTEXAI\"] = \"FALSE\"\n",
    "\n",
    "print(\"Gemini API key loaded!\")"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "7c43d366",
   "metadata": {},
   "source": [
    "### Import ADK"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 9,
   "id": "b43597b2",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "âœ… ADK components imported successfully.\n"
     ]
    }
   ],
   "source": [
    "from typing import Any, Dict\n",
    "\n",
    "from google.adk.agents import Agent, LlmAgent\n",
    "from google.adk.apps.app import App, EventsCompactionConfig\n",
    "from google.adk.models.google_llm import Gemini\n",
    "from google.adk.sessions import DatabaseSessionService\n",
    "from google.adk.sessions import InMemorySessionService\n",
    "from google.adk.runners import Runner\n",
    "from google.adk.tools.tool_context import ToolContext\n",
    "from google.genai import types\n",
    "\n",
    "print(\"âœ… ADK components imported successfully.\")"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 10,
   "id": "c7f64764",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "âœ… Helper functions defined.\n"
     ]
    }
   ],
   "source": [
    "# Define helper functions that will be reused throughout the notebook\n",
    "async def run_session(\n",
    "    runner_instance: Runner,\n",
    "    user_queries: list[str] | str = None,\n",
    "    session_name: str = \"default\",\n",
    "):\n",
    "    print(f\"\\n ### Session: {session_name}\")\n",
    "\n",
    "    # Get app name from the Runner\n",
    "    app_name = runner_instance.app_name\n",
    "\n",
    "    # Attempt to create a new session or retrieve an existing one\n",
    "    try:\n",
    "        session = await session_service.create_session(\n",
    "            app_name=app_name, user_id=USER_ID, session_id=session_name\n",
    "        )\n",
    "    except:\n",
    "        session = await session_service.get_session(\n",
    "            app_name=app_name, user_id=USER_ID, session_id=session_name\n",
    "        )\n",
    "\n",
    "    # Process queries if provided\n",
    "    if user_queries:\n",
    "        # Convert single query to list for uniform processing\n",
    "        if type(user_queries) == str:\n",
    "            user_queries = [user_queries]\n",
    "\n",
    "        # Process each query in the list sequentially\n",
    "        for query in user_queries:\n",
    "            print(f\"\\nUser > {query}\")\n",
    "\n",
    "            # Convert the query string to the ADK Content format\n",
    "            query = types.Content(role=\"user\", parts=[types.Part(text=query)])\n",
    "\n",
    "            # Stream the agent's response asynchronously\n",
    "            async for event in runner_instance.run_async(\n",
    "                user_id=USER_ID, session_id=session.id, new_message=query\n",
    "            ):\n",
    "                # Check if the event contains valid content\n",
    "                if event.content and event.content.parts:\n",
    "                    # Filter out empty or \"None\" responses before printing\n",
    "                    if (\n",
    "                        event.content.parts[0].text != \"None\"\n",
    "                        and event.content.parts[0].text\n",
    "                    ):\n",
    "                        print(f\"{MODEL_NAME} > \", event.content.parts[0].text)\n",
    "    else:\n",
    "        print(\"No queries!\")\n",
    "\n",
    "\n",
    "print(\"âœ… Helper functions defined.\")"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "163ac6b1",
   "metadata": {},
   "source": [
    "### Configure Retry Options\n",
    "\n",
    "When working with LLMs, you may encounter transient errors like rate limits or temporary service unavailability. Retry options automatically handle these failures by retrying the request with exponential backoff."
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 11,
   "id": "770c5642",
   "metadata": {},
   "outputs": [],
   "source": [
    "retry_config = types.HttpRetryOptions(\n",
    "    attempts=5,  # Maximum retry attempts\n",
    "    exp_base=7,  # Delay multiplier\n",
    "    initial_delay=1,\n",
    "    http_status_codes=[429, 500, 503, 504],  # Retry on these HTTP errors\n",
    ")"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "8648fdcf",
   "metadata": {},
   "source": [
    "### ðŸ¤¹ Section 2: Session ManagementÂ¶\n",
    "#### 2.1 The Problem\n",
    "At their core, Large Language Models are inherently stateless. Their awareness is confined to the information you provide in a single API call. This means an agent without proper context management will react to the current prompt without considering any previous history.\n",
    "\n",
    "â“ Why does this matter? Imagine trying to have a meaningful conversation with someone who forgets everything you've said after each sentence. That's the challenge we face with raw LLMs!\n",
    "\n",
    "In ADK, we use Sessions for short term memory management and Memory for long term memory. In the next notebook, you'll focus on Memory.\n",
    "\n",
    "#### 2.2 What is a Session?\n",
    "ðŸ“¦ Session\n",
    "A session is a container for conversations. It encapsulates the conversation history in a chronological manner and also records all tool interactions and responses for a single, continuous conversation. A session is tied to a user and agent; it is not shared with other users. Similarly, a session history for an Agent is not shared with other Agents.\n",
    "\n",
    "In ADK, a Session is comprised of two key components Events and State:\n",
    "\n",
    "ðŸ“ Session.Events:\n",
    "\n",
    "While a session is a container for conversations, Events are the building blocks of a conversation.\n",
    "\n",
    "Example of Events:\n",
    "\n",
    "User Input: A message from the user (text, audio, image, etc.)\n",
    "Agent Response: The agent's reply to the user\n",
    "Tool Call: The agent's decision to use an external tool or API\n",
    "Tool Output: The data returned from a tool call, which the agent uses to continue its reasoning\n",
    "{} Session.State:\n",
    "\n",
    "session.state is the Agent's scratchpad, where it stores and updates dynamic details needed during the conversation. Think of it as a global {key, value} pair storage which is available to all subagents and tools."
   ]
  },
  {
   "cell_type": "markdown",
   "id": "5addf312",
   "metadata": {},
   "source": [
    "#### 2.3 How to manage sessions?Â¶\n",
    "An agentic application can have multiple users and each user may have multiple sessions with the application. To manage these sessions and events, ADK offers a Session Manager and Runner.\n",
    "\n",
    "SessionService: The storage layer\n",
    "\n",
    "Manages creation, storage, and retrieval of session data\n",
    "Different implementations for different needs (memory, database, cloud)\n",
    "Runner: The orchestration layer\n",
    "\n",
    "Manages the flow of information between user and agent\n",
    "Automatically maintains conversation history\n",
    "Handles the Context Engineering behind the scenes\n",
    "Think of it like this:\n",
    "\n",
    "Session = A notebook ðŸ““\n",
    "Events = Individual entries in a single page ðŸ“\n",
    "SessionService = The filing cabinet storing notebooks ðŸ—„ï¸\n",
    "Runner = The assistant managing the conversation ðŸ¤–\n",
    "#### 2.4 Implementing Our First Stateful Agent\n",
    "Let's build our first stateful agent, that can remember and have constructive conversations.\n",
    "\n",
    "ADK offers different types of sessions suitable for different needs. As a start, we'll start with a simple Session Management option (InMemorySessionService):"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 12,
   "id": "1fc15342",
   "metadata": {},
   "outputs": [
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "App name mismatch detected. The runner is configured with app name \"default\", but the root agent was loaded from \"F:\\AI-Agents-ADK\\agents\\Lib\\site-packages\\google\\adk\\agents\", which implies app name \"agents\".\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "âœ… Stateful agent initialized!\n",
      "   - Application: default\n",
      "   - User: default\n",
      "   - Using: InMemorySessionService\n"
     ]
    }
   ],
   "source": [
    "APP_NAME = \"default\"  # Application\n",
    "USER_ID = \"default\"  # User\n",
    "SESSION = \"default\"  # Session\n",
    "\n",
    "MODEL_NAME = \"gemini-2.5-flash-lite\"\n",
    "\n",
    "\n",
    "# Step 1: Create the LLM Agent\n",
    "root_agent = Agent(\n",
    "    model=Gemini(model=\"gemini-2.5-flash-lite\", retry_options=retry_config),\n",
    "    name=\"text_chat_bot\",\n",
    "    description=\"A text chatbot\",  # Description of the agent's purpose\n",
    ")\n",
    "\n",
    "# Step 2: Set up Session Management\n",
    "# InMemorySessionService stores conversations in RAM (temporary)\n",
    "session_service = InMemorySessionService()\n",
    "\n",
    "# Step 3: Create the Runner\n",
    "runner = Runner(agent=root_agent, app_name=APP_NAME, session_service=session_service)\n",
    "\n",
    "print(\"âœ… Stateful agent initialized!\")\n",
    "print(f\"   - Application: {APP_NAME}\")\n",
    "print(f\"   - User: {USER_ID}\")\n",
    "print(f\"   - Using: {session_service.__class__.__name__}\")"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "8acf3b09",
   "metadata": {},
   "source": [
    "#### 2.5 Testing Our Stateful AgentÂ¶\n",
    "Now let's see the magic of sessions in action!"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 13,
   "id": "c298fff1",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "\n",
      " ### Session: stateful-agentic-session\n",
      "\n",
      "User > Hi, I am Nikhil! What is the capital of Hungary?\n",
      "gemini-2.5-flash-lite >  Hi Nikhil! The capital of Hungary is Budapest.\n",
      "\n",
      "User > Hello! What is my name?\n",
      "gemini-2.5-flash-lite >  Your name is Nikhil.\n"
     ]
    }
   ],
   "source": [
    "# Run a conversation with two queries in the same session\n",
    "# Notice: Both queries are part of the SAME session, so context is maintained\n",
    "await run_session(\n",
    "    runner,\n",
    "    [\n",
    "        \"Hi, I am Nikhil! What is the capital of Hungary?\",\n",
    "        \"Hello! What is my name?\",  # This time, the agent should remember!\n",
    "    ],\n",
    "    \"stateful-agentic-session\",\n",
    ")"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "bcfdce99",
   "metadata": {},
   "source": [
    "### ðŸŽ‰ Success! The agent remembered your name because both queries were part of the same session. The Runner automatically maintained the conversation history.\n",
    "\n",
    "But there's a catch: InMemorySessionService is temporary. Once the application stops, all conversation history is lost."
   ]
  },
  {
   "cell_type": "markdown",
   "id": "826524ac",
   "metadata": {},
   "source": [
    "### Session information is not persistent (i.e., meaningful conversations are lost). While this is advantageous in testing environments, in the real world, a user should be able to refer from past and resume conversations. To achieve this, we must persist information."
   ]
  },
  {
   "cell_type": "markdown",
   "id": "40cf1053",
   "metadata": {},
   "source": [
    "### ðŸ“ˆ Section 3: Persistent Sessions with DatabaseSessionService\n",
    "While InMemorySessionService is great for prototyping, real-world applications need conversations to survive restarts, crashes, and deployments. Let's level up to persistent storage!\n",
    "\n",
    "#### 3.1 Choosing the Right SessionService\n",
    "ADK provides different SessionService implementations for different needs:\n",
    "\n",
    "Service\tUse Case\tPersistence\tBest For\n",
    "InMemorySessionService\tDevelopment & Testing\tâŒ Lost on restart\tQuick prototypes\n",
    "DatabaseSessionService\tSelf-managed apps\tâœ… Survives restarts\tSmall to medium apps\n",
    "Agent Engine Sessions\tProduction on GCP\tâœ… Fully managed\tEnterprise scale\n",
    "#### 3.2 Implementing Persistent Sessions\n",
    "Let's upgrade to DatabaseSessionService using SQLite. This gives us persistence without needing a separate database server for this demo.\n",
    "\n",
    "Let's create a chatbot_agent capable of having a conversation with the user."
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 14,
   "id": "bc1ef4b4",
   "metadata": {},
   "outputs": [
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "App name mismatch detected. The runner is configured with app name \"default\", but the root agent was loaded from \"F:\\AI-Agents-ADK\\agents\\Lib\\site-packages\\google\\adk\\agents\", which implies app name \"agents\".\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "âœ… Upgraded to persistent sessions!\n",
      "   - Database: my_agent_data.db\n",
      "   - Sessions will survive restarts!\n"
     ]
    }
   ],
   "source": [
    "# Step 1: Create the same agent (notice we use LlmAgent this time)\n",
    "chatbot_agent = LlmAgent(\n",
    "    model=Gemini(model=\"gemini-2.5-flash-lite\", retry_options=retry_config),\n",
    "    name=\"text_chat_bot\",\n",
    "    description=\"A text chatbot with persistent memory\",\n",
    ")\n",
    "\n",
    "# Step 2: Switch to DatabaseSessionService\n",
    "# SQLite database will be created automatically\n",
    "db_url = \"sqlite:///my_agent_data.db\"  # Local SQLite file\n",
    "session_service = DatabaseSessionService(db_url=db_url)\n",
    "\n",
    "# Step 3: Create a new runner with persistent storage\n",
    "runner = Runner(agent=chatbot_agent, app_name=APP_NAME, session_service=session_service)\n",
    "\n",
    "print(\"âœ… Upgraded to persistent sessions!\")\n",
    "print(f\"   - Database: my_agent_data.db\")\n",
    "print(f\"   - Sessions will survive restarts!\")"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "ff65862a",
   "metadata": {},
   "source": [
    "#### 3.3 Test Run 1: Verifying PersistenceÂ¶\n",
    "In this first test run, we'll start a new conversation with the session ID test-db-session-01. We will first introduce our name as 'Sam' and then ask a question. In the second turn, we will ask the agent for our name.\n",
    "\n",
    "Since we are using DatabaseSessionService, the agent should remember the name.\n",
    "\n",
    "After the conversation, we'll inspect the my_agent_data.db SQLite database directly to see how the conversation events (the user queries and model responses) are stored."
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 15,
   "id": "c3af4ec0",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "\n",
      " ### Session: test-db-session-01\n",
      "\n",
      "User > Hi, I am Nikhil! What is the capital of the United States?\n",
      "gemini-2.5-flash-lite >  Hello Nikhil! The capital of the United States is Washington, D.C.\n",
      "\n",
      "User > Hello! What is my name?\n",
      "gemini-2.5-flash-lite >  You told me your name is Nikhil.\n"
     ]
    }
   ],
   "source": [
    "await run_session(\n",
    "    runner,\n",
    "    [\"Hi, I am Nikhil! What is the capital of the United States?\", \"Hello! What is my name?\"],\n",
    "    \"test-db-session-01\",\n",
    ")"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "3688b9a7",
   "metadata": {},
   "source": [
    "#### 3.5 Let's verify that the session data is isolatedÂ¶\n",
    "As mentioned earlier, a session is private conversation between an Agent and a User (i.e., two sessions do not share information). Let's run our run_session with a different session name test-db-session-02 to confirm this."
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 16,
   "id": "a8f4b496",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "\n",
      " ### Session: test-db-session-02\n",
      "\n",
      "User > Hello! What is my name?\n",
      "gemini-2.5-flash-lite >  I do not have access to your personal information, including your name. I am a text chatbot and do not store any user data.\n"
     ]
    }
   ],
   "source": [
    "await run_session(\n",
    "    runner, [\"Hello! What is my name?\"], \"test-db-session-02\"\n",
    ")  # Note, we are using new session name"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "4572a85c",
   "metadata": {},
   "source": [
    "#### 3.6 How are the events stored in the Database?\n",
    "Since we are using a sqlite DB to store information, let's have a quick peek to see how information is stored."
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 17,
   "id": "7a39464f",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "['app_name', 'session_id', 'author', 'content']\n",
      "('default', 'test-db-session-01', 'user', '{\"parts\": [{\"text\": \"Hi, I am Nikhil! What is the capital of the United States?\"}], \"role\": \"user\"}')\n",
      "('default', 'test-db-session-01', 'text_chat_bot', '{\"parts\": [{\"text\": \"Hello Nikhil! The capital of the United States is Washington, D.C.\"}], \"role\": \"model\"}')\n",
      "('default', 'test-db-session-01', 'user', '{\"parts\": [{\"text\": \"Hello! What is my name?\"}], \"role\": \"user\"}')\n",
      "('default', 'test-db-session-01', 'text_chat_bot', '{\"parts\": [{\"text\": \"You told me your name is Nikhil.\"}], \"role\": \"model\"}')\n",
      "('default', 'test-db-session-02', 'user', '{\"parts\": [{\"text\": \"Hello! What is my name?\"}], \"role\": \"user\"}')\n",
      "('default', 'test-db-session-02', 'text_chat_bot', '{\"parts\": [{\"text\": \"I do not have access to your personal information, including your name. I am a text chatbot and do not store any user data.\"}], \"role\": \"model\"}')\n"
     ]
    }
   ],
   "source": [
    "import sqlite3\n",
    "\n",
    "def check_data_in_db():\n",
    "    with sqlite3.connect(\"my_agent_data.db\") as connection:\n",
    "        cursor = connection.cursor()\n",
    "        result = cursor.execute(\n",
    "            \"select app_name, session_id, author, content from events\"\n",
    "        )\n",
    "        print([_[0] for _ in result.description])\n",
    "        for each in result.fetchall():\n",
    "            print(each)\n",
    "\n",
    "\n",
    "check_data_in_db()"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "3466784c",
   "metadata": {},
   "source": [
    "### â³ Section 4: Context CompactionÂ¶\n",
    "As you can see, all the events are stored in full in the session Database, and this quickly adds up. For a long, complex task, this list of events can become very large, leading to slower performance and higher costs.\n",
    "\n",
    "But what if we could automatically summarize the past? Let's use ADK's Context Compaction feature to see how to automatically reduce the context that's stored in the Session."
   ]
  },
  {
   "cell_type": "markdown",
   "id": "3cf28dfe",
   "metadata": {},
   "source": [
    "#### 4.1 Create an App for the agentÂ¶\n",
    "To enable this feature, let's use the same chatbot_agent we created in Section 3.2.\n",
    "\n",
    "The first step is to create an object called App. We'll give it a name and pass in our chatbot_agent.\n",
    "\n",
    "We'll also create a new config to do the Context Compaction. This EventsCompactionConfig defines two key variables:\n",
    "\n",
    "compaction_interval: Asks the Runner to compact the history after every n conversations\n",
    "overlap_size: Defines the number of previous conversations to retain for overlap\n",
    "We'll then provide this app to the Runner."
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 18,
   "id": "60698b2b",
   "metadata": {},
   "outputs": [
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "C:\\Users\\Nikhil Bhardwaj\\AppData\\Local\\Temp\\ipykernel_11440\\3773147741.py:6: UserWarning: [EXPERIMENTAL] EventsCompactionConfig: This feature is experimental and may change or be removed in future versions without notice. It may introduce breaking changes at any time.\n",
      "  events_compaction_config=EventsCompactionConfig(\n",
      "App name mismatch detected. The runner is configured with app name \"research_app_compacting\", but the root agent was loaded from \"F:\\AI-Agents-ADK\\agents\\Lib\\site-packages\\google\\adk\\agents\", which implies app name \"agents\".\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "âœ… Research App upgraded with Events Compaction!\n"
     ]
    }
   ],
   "source": [
    "# Re-define our app with Events Compaction enabled\n",
    "research_app_compacting = App(\n",
    "    name=\"research_app_compacting\",\n",
    "    root_agent=chatbot_agent,\n",
    "    # This is the new part!\n",
    "    events_compaction_config=EventsCompactionConfig(\n",
    "        compaction_interval=3,  # Trigger compaction every 3 invocations\n",
    "        overlap_size=1,  # Keep 1 previous turn for context\n",
    "    ),\n",
    ")\n",
    "\n",
    "db_url = \"sqlite:///my_agent_data.db\"  # Local SQLite file\n",
    "session_service = DatabaseSessionService(db_url=db_url)\n",
    "\n",
    "# Create a new runner for our upgraded app\n",
    "research_runner_compacting = Runner(\n",
    "    app=research_app_compacting, session_service=session_service\n",
    ")\n",
    "\n",
    "\n",
    "print(\"âœ… Research App upgraded with Events Compaction!\")"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "5f6eb653",
   "metadata": {},
   "source": [
    "#### 4.2 Running the Demo\n",
    "Now, let's have a conversation that is long enough to trigger the compaction. When you run the cell below, the output will look like a normal conversation. However, because we configured our App, a compaction process will run silently in the background after the 3rd invocation.\n",
    "\n",
    "In the next step, we'll prove that it happened."
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 19,
   "id": "e3384996",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "\n",
      " ### Session: compaction_demo\n",
      "\n",
      "User > What is the latest news about AI in healthcare?\n",
      "gemini-2.5-flash-lite >  Here's a summary of some of the latest news and trends in AI in healthcare:\n",
      "\n",
      "**Key Areas of Progress and Focus:**\n",
      "\n",
      "*   **Drug Discovery and Development:** AI continues to be a game-changer in speeding up the identification of potential drug candidates, predicting their efficacy and toxicity, and optimizing clinical trial design. Recent advancements include AI models that can design novel molecules from scratch and identify existing drugs that could be repurposed for new conditions.\n",
      "*   **Diagnostic Imaging and Pathology:** AI algorithms are becoming increasingly sophisticated at analyzing medical images (X-rays, CT scans, MRIs, pathology slides) to detect diseases like cancer, diabetic retinopathy, and cardiovascular conditions with accuracy often matching or exceeding human experts. There's a growing focus on making these tools more accessible and integrated into clinical workflows.\n",
      "*   **Personalized Medicine and Treatment:** AI is crucial for analyzing vast amounts of patient data (genomic, clinical, lifestyle) to tailor treatment plans to individual needs, predict disease risk, and optimize drug dosages. This is leading to more effective and less toxic therapies.\n",
      "*   **Administrative and Operational Efficiency:** AI-powered tools are automating tasks like medical coding, appointment scheduling, prior authorization, and clinical documentation, freeing up healthcare professionals to focus on patient care. Natural Language Processing (NLP) plays a significant role here.\n",
      "*   **Remote Patient Monitoring and Wearables:** AI is being integrated into wearable devices and remote monitoring platforms to detect early signs of health deterioration, predict exacerbations of chronic conditions, and provide proactive interventions.\n",
      "*   **Mental Health:** AI is being explored for early detection of mental health conditions through analysis of speech patterns, text, and behavioral data. Chatbots are also being developed to provide accessible mental health support and therapy.\n",
      "*   **Generative AI in Healthcare:** This is a rapidly evolving area. Generative AI (like large language models) is being explored for:\n",
      "    *   **Summarizing patient records:** Quickly condensing lengthy medical histories.\n",
      "    *   **Drafting clinical notes and reports:** Assisting clinicians with documentation.\n",
      "    *   **Creating educational materials:** Developing patient-friendly explanations of conditions and treatments.\n",
      "    *   **Simulating patient scenarios:** Training medical students and professionals.\n",
      "    *   **Answering complex medical questions:** Providing accessible information.\n",
      "\n",
      "**Recent Developments and Trends to Watch:**\n",
      "\n",
      "*   **Regulatory Scrutiny and Approval:** As AI in healthcare becomes more prevalent, regulatory bodies like the FDA are actively developing frameworks and guidelines for approving AI-powered medical devices and software. The focus is on ensuring safety, efficacy, and fairness.\n",
      "*   **Data Privacy and Security:** With the use of sensitive patient data, robust data privacy and security measures are paramount. Innovations in areas like federated learning (training AI models without directly accessing raw data) are gaining traction.\n",
      "*   **Ethical Considerations and Bias:** Addressing bias in AI algorithms is a critical ongoing challenge. Ensuring that AI tools are equitable across different patient populations is a major focus. Discussions around accountability and transparency are also intensifying.\n",
      "*   **Interoperability and Integration:** A key hurdle is integrating AI solutions seamlessly into existing healthcare IT systems. Efforts are underway to improve data sharing and interoperability between different platforms.\n",
      "*   **The Rise of Specialized AI Companies:** A significant number of startups and established tech companies are dedicating substantial resources to developing AI solutions specifically for healthcare.\n",
      "*   **AI as a \"Co-pilot\" for Clinicians:** The trend is moving towards AI as a tool to augment human capabilities rather than replace them. AI acts as a \"co-pilot\" to assist doctors, nurses, and researchers in making better, faster decisions.\n",
      "\n",
      "**Challenges Remain:**\n",
      "\n",
      "Despite the rapid progress, significant challenges persist, including:\n",
      "\n",
      "*   **Data availability and quality:** Access to diverse, high-quality, and representative datasets is crucial for training robust AI models.\n",
      "*   **Clinical validation and adoption:** Proving the real-world value and gaining widespread adoption by healthcare professionals requires rigorous validation and trust-building.\n",
      "*   **Cost and scalability:** Implementing and scaling AI solutions across healthcare systems can be expensive.\n",
      "*   **Explainability (XAI):** Understanding how AI models arrive at their conclusions (especially in critical diagnostic situations) is vital for trust and regulatory compliance.\n",
      "\n",
      "In summary, AI in healthcare is a dynamic field experiencing rapid innovation, particularly in areas like drug discovery, diagnostics, and personalized medicine. While challenges related to regulation, ethics, and implementation remain, the potential for AI to transform healthcare delivery and improve patient outcomes is immense.\n",
      "\n",
      " ### Session: compaction_demo\n",
      "\n",
      "User > Are there any new developments in drug discovery?\n",
      "gemini-2.5-flash-lite >  Yes, there are constant and exciting new developments in drug discovery, with AI playing a truly transformative role. Here are some of the key areas where new progress is being made:\n",
      "\n",
      "**1. AI-Powered Target Identification and Validation:**\n",
      "\n",
      "*   **Uncovering Novel Biological Targets:** AI algorithms can analyze vast datasets of genomic, proteomic, and clinical information to identify previously unknown biological targets that are implicated in diseases. This goes beyond traditional, well-understood pathways.\n",
      "*   **Predicting Target Druggability:** AI models can assess whether a newly identified target is likely to be \"druggable\" â€“ meaning a molecule can be designed to interact with it effectively.\n",
      "\n",
      "**2. De Novo Drug Design and Optimization:**\n",
      "\n",
      "*   **Generating Novel Molecules:** Instead of screening existing compound libraries, generative AI models (like Generative Adversarial Networks - GANs, and Variational Autoencoders - VAEs) can design entirely new molecules with desired properties from scratch. This is a paradigm shift.\n",
      "*   **Optimizing Lead Compounds:** Once an initial promising molecule (a \"lead compound\") is found, AI can rapidly iterate and suggest modifications to improve its potency, selectivity, solubility, and pharmacokinetic properties (how the body processes the drug).\n",
      "\n",
      "**3. Accelerating Preclinical Research:**\n",
      "\n",
      "*   **Predicting Compound Efficacy and Toxicity:** AI can predict how effective a potential drug candidate will be and its potential side effects *in silico* (using computer simulations) before costly and time-consuming lab experiments. This helps to de-risk candidates earlier.\n",
      "*   **Automating and Enhancing In Vitro Assays:** AI is being used to analyze the results of laboratory experiments more efficiently and accurately.\n",
      "\n",
      "**4. Revolutionizing Clinical Trials:**\n",
      "\n",
      "*   **Optimizing Trial Design:** AI can help identify the most suitable patient populations for a trial, predict patient response, and even simulate trial outcomes to optimize dosage regimens and trial duration.\n",
      "*   **Identifying Trial Sites and Investigators:** AI can analyze data to pinpoint the best locations and researchers for specific clinical trials.\n",
      "*   **Patient Recruitment:** AI can sift through electronic health records (EHRs) to identify eligible patients for trials more efficiently.\n",
      "\n",
      "**5. Repurposing Existing Drugs:**\n",
      "\n",
      "*   **Finding New Uses for Old Drugs:** AI can analyze the molecular profiles of existing drugs and disease pathways to identify potential new therapeutic uses for drugs already approved for other conditions. This significantly reduces development time and cost.\n",
      "\n",
      "**6. Advanced AI Techniques Being Applied:**\n",
      "\n",
      "*   **Graph Neural Networks (GNNs):** These are proving very effective for representing and learning from molecular structures and biological networks.\n",
      "*   **Transformer Models (like those in LLMs):** While known for language, these models are being adapted to understand and generate complex biological sequences (like protein sequences) and chemical structures.\n",
      "*   **Reinforcement Learning:** This is being used to guide the drug design process, where the AI \"learns\" to design molecules that achieve specific goals.\n",
      "\n",
      "**Examples of Recent Progress (Illustrative):**\n",
      "\n",
      "*   **Companies like Atomwise, Insilico Medicine, Recursion Pharmaceuticals, and BenevolentAI** are at the forefront, announcing partnerships and breakthroughs in discovering novel drug candidates for various diseases, from cancer to neurodegenerative disorders.\n",
      "*   **Specific examples** might include AI identifying novel targets for difficult-to-treat cancers, or designing small molecules that can inhibit specific enzymes involved in viral replication.\n",
      "\n",
      "**The Overall Impact:**\n",
      "\n",
      "The overarching goal of these AI advancements in drug discovery is to:\n",
      "\n",
      "*   **Dramatically reduce the time and cost** of bringing new medicines to market.\n",
      "*   **Increase the success rate** of drug development, which has historically been very low.\n",
      "*   **Develop more effective and personalized therapies** for a wider range of diseases.\n",
      "\n",
      "While challenges like experimental validation and regulatory hurdles remain, the pace of innovation in AI-driven drug discovery is incredibly rapid, promising a future with faster access to life-saving treatments.\n",
      "\n",
      " ### Session: compaction_demo\n",
      "\n",
      "User > Tell me more about the second development you found.\n",
      "gemini-2.5-flash-lite >  You're asking about the **second development** I mentioned, which was:\n",
      "\n",
      "**2. De Novo Drug Design and Optimization:**\n",
      "\n",
      "This is a particularly exciting area because it represents a fundamental shift in how we approach creating new medicines.\n",
      "\n",
      "**What is \"De Novo\" Drug Design?**\n",
      "\n",
      "\"De Novo\" is Latin for \"from the beginning\" or \"anew.\" In the context of drug discovery, de novo drug design refers to the process of **creating entirely novel molecular structures that are specifically designed to interact with a particular biological target and exhibit desired therapeutic properties.**\n",
      "\n",
      "Traditionally, drug discovery often involved:\n",
      "\n",
      "*   **Screening vast libraries** of existing chemical compounds to see if any of them showed activity against a target.\n",
      "*   **Modifying existing drugs** or known active molecules.\n",
      "\n",
      "De novo design, empowered by AI, bypasses much of this trial-and-error by *generating* potential drug candidates.\n",
      "\n",
      "**How AI Enables De Novo Drug Design:**\n",
      "\n",
      "AI, particularly **generative AI models**, are the driving force behind this development. Here's how it works:\n",
      "\n",
      "*   **Learning the Rules of Chemistry and Biology:** AI models are trained on massive datasets of known molecules, their chemical properties, and their biological activities. They learn the complex relationships between molecular structure and function, essentially learning the \"language\" of chemistry and how molecules interact with biological systems.\n",
      "*   **Generative Models:** These AI models can then *generate* new data points â€“ in this case, new molecular structures. Common types of generative models used include:\n",
      "    *   **Generative Adversarial Networks (GANs):** These involve two neural networks (a generator and a discriminator) that compete. The generator tries to create realistic molecules, while the discriminator tries to distinguish between real and generated molecules. This competition drives the generator to produce increasingly novel and valid structures.\n",
      "    *   **Variational Autoencoders (VAEs):** These models learn a compressed representation (a \"latent space\") of existing molecules and can then sample from this space to generate new, similar molecules.\n",
      "    *   **Reinforcement Learning:** In some approaches, reinforcement learning can be used to guide the generation process. The AI is \"rewarded\" for creating molecules that meet specific criteria (e.g., high binding affinity to a target, good solubility).\n",
      "*   **Defining Objectives and Constraints:** Researchers provide the AI with specific objectives, such as:\n",
      "    *   **Target binding affinity:** How strongly the molecule will bind to the disease-causing protein.\n",
      "    *   **Selectivity:** Ensuring the molecule binds only to the intended target and not others (to minimize side effects).\n",
      "    *   **Pharmacokinetic properties (ADME):** How the drug will be Absorbed, Distributed, Metabolized, and Excreted by the body.\n",
      "    *   **Physicochemical properties:** Solubility, stability, etc.\n",
      "*   **Iterative Design and Optimization:** The AI can generate thousands or even millions of candidate molecules. These candidates are then filtered and ranked based on their predicted properties. Promising molecules can be fed back into the AI for further refinement and optimization, creating a rapid, iterative design cycle.\n",
      "\n",
      "**Benefits of De Novo AI Drug Design:**\n",
      "\n",
      "*   **Novelty:** It can create completely new chemical entities that might not have been conceived by human chemists, potentially leading to breakthrough therapies.\n",
      "*   **Speed:** It can drastically accelerate the early stages of drug discovery, moving from target identification to candidate generation in a fraction of the time.\n",
      "*   **Efficiency:** By generating molecules with a higher probability of success, it can reduce the number of compounds that need to be synthesized and tested experimentally.\n",
      "*   **Tackling Difficult Targets:** It offers a powerful approach for designing drugs against challenging biological targets that have been historically difficult to drug.\n",
      "\n",
      "**Examples in Action:**\n",
      "\n",
      "*   **Designing Inhibitors for Resistance Mutations:** AI can design molecules that are effective against mutated proteins that have become resistant to existing drugs.\n",
      "*   **Creating Allosteric Modulators:** AI can be used to design molecules that bind to a different site on a protein (an allosteric site) to alter its activity, a more complex task than designing direct inhibitors.\n",
      "*   **Personalized Drug Design:** In the future, AI could potentially design drugs tailored to an individual's specific genetic makeup or disease profile.\n",
      "\n",
      "In essence, AI-powered de novo drug design is like having a highly intelligent, super-fast molecular architect that can build custom-designed molecules from the ground up, specifically engineered to combat disease.\n",
      "\n",
      " ### Session: compaction_demo\n",
      "\n",
      "User > Who are the main companies involved in that?\n",
      "gemini-2.5-flash-lite >  You're asking about the main companies involved in **AI-powered de novo drug design**. This is a rapidly evolving space with a mix of dedicated AI drug discovery companies and larger pharmaceutical giants leveraging these technologies.\n",
      "\n",
      "Here are some of the key players, categorized for clarity:\n",
      "\n",
      "**1. Dedicated AI Drug Discovery Companies (often specializing in De Novo Design):**\n",
      "\n",
      "These companies have made AI, and often de novo design, the core of their business model.\n",
      "\n",
      "*   **Insilico Medicine:** A prominent leader, known for its AI-driven end-to-end drug discovery platform. They have advanced several AI-designed molecules into clinical trials, including for conditions like idiopathic pulmonary fibrosis and cancer. They are very vocal about their use of generative AI for novel molecule design.\n",
      "*   **Recursion Pharmaceuticals:** While they have a broad AI platform for drug discovery and development, they heavily utilize AI to identify novel targets and design molecules. Their platform uses imaging and genomics data to understand disease biology, which then informs their generative design efforts.\n",
      "*   **Atomwise:** One of the earlier pioneers in using deep learning for drug discovery. They focus on structure-based drug design, using AI to predict how small molecules will bind to protein targets, which is a crucial step in de novo design to ensure efficacy.\n",
      "*   **Exscientia:** This company leverages AI to automate and accelerate the design of new molecules. They aim to significantly reduce the time it takes to move from target identification to a clinical candidate, with a strong emphasis on generative design principles.\n",
      "*   **BenevolentAI:** They use AI to analyze vast amounts of biomedical data to identify novel targets and then apply generative AI to design potential drugs. They have a broad approach across various therapeutic areas.\n",
      "*   **Generate:Biologics (part of Generate Biomedicines):** While often focusing on protein therapeutics, their generative AI platform is capable of designing novel biological molecules, including antibodies and enzymes, which can be considered a form of de novo design for biologics.\n",
      "\n",
      "**2. Big Pharma Companies with Significant AI Initiatives (including De Novo Design Capabilities):**\n",
      "\n",
      "Major pharmaceutical companies are heavily investing in and integrating AI, including de novo design, into their R&D pipelines. They often do this through internal development, partnerships with AI biotech firms, or acquisitions.\n",
      "\n",
      "*   **Pfizer:** Has been actively exploring AI for drug discovery, including generative AI for molecule design. They've announced collaborations and internal initiatives.\n",
      "*   **Novartis:** A major player in pharmaceutical R&D, Novartis has been investing in AI and machine learning to accelerate various stages of drug discovery, including the design of novel compounds.\n",
      "*   **Merck:** Similar to others, Merck is exploring AI for target identification, hit identification, and lead optimization, which are all components of the de novo design process.\n",
      "*   **Sanofi:** Sanofi has been vocal about its commitment to AI and digital transformation in R&D, including its use of AI for designing novel drug candidates.\n",
      "*   **Johnson & Johnson:** J&J has a strong focus on innovation and is employing AI across its pharmaceutical R&D, including for generating and optimizing new molecular entities.\n",
      "*   **AstraZeneca:** They have established AI innovation hubs and are using AI for various discovery and development tasks, including the design of new chemical entities.\n",
      "\n",
      "**3. Emerging Players and Research Institutions:**\n",
      "\n",
      "*   Numerous **startups** are emerging in this space, often with novel approaches or focusing on niche therapeutic areas.\n",
      "*   **Academic research institutions** are also critical in developing the fundamental AI algorithms and methodologies that power de novo design.\n",
      "\n",
      "**Important Considerations:**\n",
      "\n",
      "*   **Partnerships are Key:** Many of the large pharma companies collaborate with the dedicated AI biotech firms. This allows them to leverage specialized AI expertise while the AI companies gain access to pharma's vast drug development infrastructure and clinical trial expertise.\n",
      "*   **Evolving Landscape:** This field is extremely dynamic. New companies are constantly emerging, and existing ones are expanding their capabilities.\n",
      "*   **\"De Novo\" is a Spectrum:** While some companies focus purely on generating entirely new scaffolds, others use AI to optimize existing scaffolds in a de novo manner.\n",
      "\n",
      "When looking into this area, it's worth noting that while many companies claim AI capabilities, those that are truly pushing the boundaries of *de novo* design are typically those employing advanced generative models and demonstrating successful progression of AI-designed molecules into preclinical and clinical development.\n"
     ]
    }
   ],
   "source": [
    "# Turn 1\n",
    "await run_session(\n",
    "    research_runner_compacting,\n",
    "    \"What is the latest news about AI in healthcare?\",\n",
    "    \"compaction_demo\",\n",
    ")\n",
    "\n",
    "# Turn 2\n",
    "await run_session(\n",
    "    research_runner_compacting,\n",
    "    \"Are there any new developments in drug discovery?\",\n",
    "    \"compaction_demo\",\n",
    ")\n",
    "\n",
    "# Turn 3 - Compaction should trigger after this turn!\n",
    "await run_session(\n",
    "    research_runner_compacting,\n",
    "    \"Tell me more about the second development you found.\",\n",
    "    \"compaction_demo\",\n",
    ")\n",
    "\n",
    "# Turn 4\n",
    "await run_session(\n",
    "    research_runner_compacting,\n",
    "    \"Who are the main companies involved in that?\",\n",
    "    \"compaction_demo\",\n",
    ")"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "4eb0b0f3",
   "metadata": {},
   "source": [
    "#### 4.3 Verifying Compaction in the Session History\n",
    "The conversation above looks normal, but the history has been changed behind the scenes. How can we prove it?\n",
    "\n",
    "We can inspect the events list from our session. The compaction process doesn't delete old events; it replaces them with a single, new Event that contains the summary. Let's find it."
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 20,
   "id": "56799b48",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "--- Searching for Compaction Summary Event ---\n",
      "\n",
      "âœ… SUCCESS! Found the Compaction Event:\n",
      "  Author: user\n",
      "\n",
      " Compacted information: model_version=None content=None grounding_metadata=None partial=None turn_complete=None finish_reason=None error_code=None error_message=None interrupted=None custom_metadata=None usage_metadata=None live_session_resumption_update=None input_transcription=None output_transcription=None avg_logprobs=None logprobs_result=None cache_metadata=None citation_metadata=None invocation_id='276fbe66-60ef-4d39-9f1b-48dcc83bc5f1' author='user' actions=EventActions(skip_summarization=None, state_delta={}, artifact_delta={}, transfer_to_agent=None, escalate=None, requested_auth_configs={}, requested_tool_confirmations={}, compaction={'start_timestamp': 1763011413.414163, 'end_timestamp': 1763011421.811462, 'compacted_content': {'parts': [{'function_call': None, 'code_execution_result': None, 'executable_code': None, 'file_data': None, 'function_response': None, 'inline_data': None, 'text': 'The user inquired about the latest news in AI in healthcare. The AI provided a comprehensive overview covering key areas like drug discovery, diagnostic imaging, personalized medicine, administrative efficiency, remote monitoring, and mental health. It also highlighted emerging trends such as generative AI in healthcare and the \"co-pilot\" model for clinicians, alongside ongoing challenges like data quality, ethical considerations, and explainability.\\n\\nFollowing this, the user specifically asked for more details on AI in drug discovery. The AI elaborated on several advancements, including AI-powered target identification, de novo drug design and optimization, accelerated preclinical research, revolutionizing clinical trials, and drug repurposing. It also mentioned the advanced AI techniques being applied, such as Graph Neural Networks and Transformer models.\\n\\nThe user then requested more information on the \"De Novo Drug Design and Optimization\" aspect. The AI explained that \"de novo\" means designing entirely novel molecular structures from scratch. It detailed how generative AI models (GANs, VAEs, Reinforcement Learning) are trained on chemical and biological data to generate molecules with specific desired properties (target binding, selectivity, ADME, etc.). The AI emphasized the benefits of this approach, including novelty, speed, efficiency, and its potential to tackle difficult targets. It also provided illustrative examples of its application.\\n\\n**Key Information and Decisions:**\\n\\n*   The AI successfully provided a broad overview of AI in healthcare and then a focused explanation on drug discovery advancements.\\n*   The user\\'s specific interest in \"De Novo Drug Design\" was identified and addressed in detail.\\n*   The conversation established that AI is significantly transforming drug discovery by enabling the creation of novel molecules from the ground up.\\n\\n**Unresolved Questions or Tasks:**\\n\\n*   None. The conversation concluded with the AI providing a detailed explanation of de novo drug design.', 'thought': None, 'thought_signature': None, 'video_metadata': None}], 'role': 'model'}}, end_of_agent=None, agent_state=None, rewind_before_invocation_id=None) long_running_tool_ids=set() branch=None id='c376c667-9cc6-4280-ba76-eba8cb64219f' timestamp=1763011428.804253\n"
     ]
    }
   ],
   "source": [
    "# Get the final session state\n",
    "final_session = await session_service.get_session(\n",
    "    app_name=research_runner_compacting.app_name,\n",
    "    user_id=USER_ID,\n",
    "    session_id=\"compaction_demo\",\n",
    ")\n",
    "\n",
    "print(\"--- Searching for Compaction Summary Event ---\")\n",
    "found_summary = False\n",
    "for event in final_session.events:\n",
    "    # Compaction events have a 'compaction' attribute\n",
    "    if event.actions and event.actions.compaction:\n",
    "        print(\"\\nâœ… SUCCESS! Found the Compaction Event:\")\n",
    "        print(f\"  Author: {event.author}\")\n",
    "        print(f\"\\n Compacted information: {event}\")\n",
    "        found_summary = True\n",
    "        break\n",
    "\n",
    "if not found_summary:\n",
    "    print(\n",
    "        \"\\nâŒ No compaction event found. Try increasing the number of turns in the demo.\"\n",
    "    )"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "65314f4b",
   "metadata": {},
   "source": [
    "#### 4.4 What you've accomplished: Automatic Context ManagementÂ¶\n",
    "You just found the proof! The presence of that special summary Event in your session's history is the tangible result of the compaction process.\n",
    "\n",
    "Let's recap what you just witnessed:\n",
    "\n",
    "Silent Operation: You ran a standard conversation, and from the outside, nothing seemed different.\n",
    "Background Compaction: Because you configured the App with EventsCompactionConfig, the ADK Runner automatically monitored the conversation length. Once the threshold was met, it triggered the summarization process in the background.\n",
    "Verified Result: By inspecting the session's events, you found the summary that the LLM generated. This summary now replaces the older, more verbose turns in the agent's active context.\n",
    "For all future turns in this conversation, the agent will be given this concise summary instead of the full history. This saves costs, improves performance, and helps the agent stay focused on what's most important.\n",
    "\n",
    "#### 4.5 More Context Engineering options in ADK\n",
    "ðŸ‘‰ Custom Compaction\n",
    "In this example, we used ADK's default summarizer. For more advanced use cases, you can provide your own by defining a custom SlidingWindowCompactor and passing it to the config. This allows you to control the summarization prompt or even use a different, specialized LLM for the task. You can read more about it in the official documentation.\n",
    "\n",
    "ðŸ‘‰ Context Caching\n",
    "ADK also provides Context Caching to help reduce the token size of the static instructions that are fed to the LLM by caching the request data. Read more about it here.\n",
    "\n",
    "The Problem\n",
    "While we can do Context Compaction and use a database to resume a session, we face new challenges now. In some cases, we have key information or preferences that we want to share across other sessions.\n",
    "\n",
    "In these scenarios, instead of sharing the entire session history, transferring information from a few key variables can improve the session experience. Let's see how to do it!"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "dc88c561",
   "metadata": {},
   "source": [
    "### ðŸ¤ Section 5: Working with Session State\n",
    "#### 5.1 Creating custom tools for Session state management\n",
    "Let's explore how to manually manage session state through custom tools. In this example, we'll identify a transferable characteristic, like a user's name and their country, and create tools to capture and save it.\n",
    "\n",
    "Why This Example?\n",
    "\n",
    "The username is a perfect example of information that:\n",
    "\n",
    "Is introduced once but referenced multiple times\n",
    "Should persist throughout a conversation\n",
    "Represents a user-specific characteristic that enhances personalization\n",
    "Here, for demo purposes, we'll create two tools that can store and retrieve user name and country from the Session State. Note that all tools have access to the ToolContext object. You don't have to create separate tools for each piece of information you want to share."
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 21,
   "id": "e0f9fce3",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "âœ… Tools created.\n"
     ]
    }
   ],
   "source": [
    "# Define scope levels for state keys (following best practices)\n",
    "USER_NAME_SCOPE_LEVELS = (\"temp\", \"user\", \"app\")\n",
    "\n",
    "\n",
    "# This demonstrates how tools can write to session state using tool_context.\n",
    "# The 'user:' prefix indicates this is user-specific data.\n",
    "def save_userinfo(\n",
    "    tool_context: ToolContext, user_name: str, country: str\n",
    ") -> Dict[str, Any]:\n",
    "    \"\"\"\n",
    "    Tool to record and save user name and country in session state.\n",
    "\n",
    "    Args:\n",
    "        user_name: The username to store in session state\n",
    "        country: The name of the user's country\n",
    "    \"\"\"\n",
    "    # Write to session state using the 'user:' prefix for user data\n",
    "    tool_context.state[\"user:name\"] = user_name\n",
    "    tool_context.state[\"user:country\"] = country\n",
    "\n",
    "    return {\"status\": \"success\"}\n",
    "\n",
    "\n",
    "# This demonstrates how tools can read from session state.\n",
    "def retrieve_userinfo(tool_context: ToolContext) -> Dict[str, Any]:\n",
    "    \"\"\"\n",
    "    Tool to retrieve user name and country from session state.\n",
    "    \"\"\"\n",
    "    # Read from session state\n",
    "    user_name = tool_context.state.get(\"user:name\", \"Username not found\")\n",
    "    country = tool_context.state.get(\"user:country\", \"Country not found\")\n",
    "\n",
    "    return {\"status\": \"success\", \"user_name\": user_name, \"country\": country}\n",
    "\n",
    "\n",
    "print(\"âœ… Tools created.\")"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "e0d936d1",
   "metadata": {},
   "source": [
    "Key Concepts:\n",
    "\n",
    "Tools can access tool_context.state to read/write session state\n",
    "Use descriptive key prefixes (user:, app:, temp:) for organization\n",
    "State persists across conversation turns within the same session\n",
    "#### 5.2 Creating an Agent with Session State Tools\n",
    "Now let's create a new agent that has access to our session state management tools:"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 22,
   "id": "b59439a9",
   "metadata": {},
   "outputs": [
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "App name mismatch detected. The runner is configured with app name \"default\", but the root agent was loaded from \"F:\\AI-Agents-ADK\\agents\\Lib\\site-packages\\google\\adk\\agents\", which implies app name \"agents\".\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "âœ… Agent with session state tools initialized!\n"
     ]
    }
   ],
   "source": [
    "# Configuration\n",
    "APP_NAME = \"default\"\n",
    "USER_ID = \"default\"\n",
    "MODEL_NAME = \"gemini-2.5-flash-lite\"\n",
    "\n",
    "# Create an agent with session state tools\n",
    "root_agent = LlmAgent(\n",
    "    model=Gemini(model=\"gemini-2.5-flash-lite\", retry_options=retry_config),\n",
    "    name=\"text_chat_bot\",\n",
    "    description=\"\"\"A text chatbot.\n",
    "    Tools for managing user context:\n",
    "    * To record username and country when provided use `save_userinfo` tool. \n",
    "    * To fetch username and country when required use `retrieve_userinfo` tool.\n",
    "    \"\"\",\n",
    "    tools=[save_userinfo, retrieve_userinfo],  # Provide the tools to the agent\n",
    ")\n",
    "\n",
    "# Set up session service and runner\n",
    "session_service = InMemorySessionService()\n",
    "runner = Runner(agent=root_agent, session_service=session_service, app_name=\"default\")\n",
    "\n",
    "print(\"âœ… Agent with session state tools initialized!\")"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "9cedb543",
   "metadata": {},
   "source": [
    "#### 5.3 Testing Session State in Action\n",
    "Let's test how the agent uses session state to remember information across conversation turns:"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 24,
   "id": "c6afcb15",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "\n",
      " ### Session: state-demo-session\n",
      "\n",
      "User > Hi there, how are you doing today? What is my name?\n",
      "gemini-2.5-flash-lite >  Hello! I'm doing great. I'm not sure what your name is, though. Can you tell me?\n",
      "\n",
      "User > My name is Nikhil. I'm from India.\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Warning: there are non-text parts in the response: ['function_call'], returning concatenated text result from text parts. Check the full candidates.content.parts accessor to get the full model response.\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "gemini-2.5-flash-lite >  It is nice to meet you, Nikhil! I have saved your information.\n",
      "\n",
      "User > What is my name? Which country am I from?\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Warning: there are non-text parts in the response: ['function_call'], returning concatenated text result from text parts. Check the full candidates.content.parts accessor to get the full model response.\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "gemini-2.5-flash-lite >  Your name is Nikhil and you are from India.\n"
     ]
    }
   ],
   "source": [
    "# Test conversation demonstrating session state\n",
    "await run_session(\n",
    "    runner,\n",
    "    [\n",
    "        \"Hi there, how are you doing today? What is my name?\",  # Agent shouldn't know the name yet\n",
    "        \"My name is Nikhil. I'm from India.\",  # Provide name - agent should save it\n",
    "        \"What is my name? Which country am I from?\",  # Agent should recall from session state\n",
    "    ],\n",
    "    \"state-demo-session\",\n",
    ")"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "3bd41310",
   "metadata": {},
   "source": [
    "#### 5.4 Inspecting Session State\n",
    "Let's directly inspect the session state to see what's stored:"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 25,
   "id": "2704ad8e",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Session State Contents:\n",
      "{'user:name': 'Nikhil', 'user:country': 'India'}\n",
      "\n",
      "ðŸ” Notice the 'user:name' and 'user:country' keys storing our data!\n"
     ]
    }
   ],
   "source": [
    "# Retrieve the session and inspect its state\n",
    "session = await session_service.get_session(\n",
    "    app_name=APP_NAME, user_id=USER_ID, session_id=\"state-demo-session\"\n",
    ")\n",
    "\n",
    "print(\"Session State Contents:\")\n",
    "print(session.state)\n",
    "print(\"\\nðŸ” Notice the 'user:name' and 'user:country' keys storing our data!\")"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "389c8cf0",
   "metadata": {},
   "source": [
    "#### 5.5 Session State Isolation\n",
    "As we've already seen, an important characteristic of session state is that it's isolated per session. Let's demonstrate this by starting a new session:"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 26,
   "id": "ae1b7703",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "\n",
      " ### Session: new-isolated-session\n",
      "\n",
      "User > Hi there, how are you doing today? What is my name?\n",
      "gemini-2.5-flash-lite >  Hello! I'm doing great, thank you for asking. I can't tell you your name just yet, as I haven't been told what it is. If you tell me your name and your country, I can save it for you. \n",
      "\n"
     ]
    }
   ],
   "source": [
    "# Start a completely new session - the agent won't know our name\n",
    "await run_session(\n",
    "    runner,\n",
    "    [\"Hi there, how are you doing today? What is my name?\"],\n",
    "    \"new-isolated-session\",\n",
    ")\n",
    "\n",
    "# Expected: The agent won't know the name because this is a different session"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "61bfe2ec",
   "metadata": {},
   "source": [
    "#### 5.6 Cross-Session State Sharing\n",
    "While sessions are isolated by default, you might notice something interesting. Let's check the state of our new session (new-isolated-session):"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 27,
   "id": "d0d241c5",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "New Session State:\n",
      "{'user:name': 'Nikhil', 'user:country': 'India'}\n"
     ]
    }
   ],
   "source": [
    "# Check the state of the new session\n",
    "session = await session_service.get_session(\n",
    "    app_name=APP_NAME, user_id=USER_ID, session_id=\"new-isolated-session\"\n",
    ")\n",
    "\n",
    "print(\"New Session State:\")\n",
    "print(session.state)\n",
    "\n",
    "# Note: Depending on implementation, you might see shared state here.\n",
    "# This is where the distinction between session-specific and user-specific state becomes important."
   ]
  }
 ],
 "metadata": {
  "kernelspec": {
   "display_name": "agents",
   "language": "python",
   "name": "python3"
  },
  "language_info": {
   "codemirror_mode": {
    "name": "ipython",
    "version": 3
   },
   "file_extension": ".py",
   "mimetype": "text/x-python",
   "name": "python",
   "nbconvert_exporter": "python",
   "pygments_lexer": "ipython3",
   "version": "3.12.7"
  }
 },
 "nbformat": 4,
 "nbformat_minor": 5
}
